Internet and Psychiatry
  • Home
    • Editorials
    • Research news
    • Research papers
    • Interviews with eminent psychiatrists
    • Ten years ago
    • Fifteen years ago
  • Topics
    • Alcohol and Drug Abuse
    • Anxiety Disorders
    • Biomedical Science
    • Compulsive gambling
    • Disaster Medicine
    • Education
    • General Medicine
      • Acupuncture
      • Physical medicine and Rehabilitation
    • Human Rights
    • Interviews with eminent psychiatrists
    • Mood Disorders
      • Bipolar Disorder
      • Depression
      • Seasonal Affective Disorder
    • Neurological Disorders
    • Other Psychiatric Disorders
    • Posttraumatic Stress Disorder
    • Sexual Behavior
  • Books
    • Comorbidity of Depression and Alcohol Use Disorders
    • “Immigration and Mental Health” chapter abstracts
    • “Internet and Suicide” chapter abstracts
    • “Neurobiology of PTSD” chapter abstracts
    • “Suicidal Behavior in Alcohol…” chapter abstracts
    • “Suicide in the Military” chapter abstracts
    • “Terror and Suicide” chapter abstracts
    • “War and Suicide” chapter abstracts
  • Editors
    • Leo Sher, M.D.
    • Alexander Vilens, M.S.
  • Guests
    • Distinguished Guests
    • Our Contributors
  • Reflections
    • Poetry
    • Quotes

"Neurobiology of PTSD" chapter abstracts

Pharmacotherapy of PTSD: An Evidence-based Review

July 1, 2012

Lakshmi N. Ravindran(1), Murray B. Stein(2), Arun V. Ravindran(1)
1. University of Toronto, Toronto, Ontario, Canada
2. University of California San Diego, La Jolla, California, USA
Neurobiology of Post-traumatic Stress Disorder. Hauppauge, New York: Nova Science Publishers, 2010, 376 pages.

Post-traumatic stress disorder (PTSD) is a common psychiatric illness with significant morbidity and impact on function. Several classes of pharmacological agents, including antidepressants, anticonvulsants, atypical antipsychotics, and several novel agents, have been investigated for the treatment of PTSD. This chapter reviews the published literature with an emphasis on randomized controlled trials. The evidence for benefit as monotherapy appears to be strongest for antidepressants, specifically SSRIs and SNRIs, with some benefit from trycyclics and MAOIs. Promising preliminary results have been reported for mirtazapine, prazosin and some anticonvulsant such as lamotrigine. Atypical antipsychotics seem to be most useful as adjunctive agents. Limited efficacy data exists on the efficacy of the combination of medication and psychotherapy but this strategy would likely benefit refractory illness. The general dearth of large, well-designed RCTs on treatments for PTSD must be noted.

Related Posts

"Neurobiology of PTSD" chapter abstracts /

Brain Adenosine Signaling in Psychological Trauma and Comorbid Depression

"Neurobiology of PTSD" chapter abstracts /

Traumatic Stress, Depression and Suicide

"Neurobiology of PTSD" chapter abstracts /

The Role of NMDA Receptors in the Pathophysiology and Treatment of Anxiety Syndromes

‹ Update on the adverse effects of clozapine: focus on myocarditis › Traumatic Stress, Depression and Suicide

Editorials

  • Monkeypox: A psychiatrist’s guide
  • Fluvoxamine attenuates COVID-19 disease
  • What? Botox injections can mitigate depressions?
  • Smoking, suicide risk, and the COVID-19 pandemic

Research Papers

  • COVID-19 mortality in Europe and the ’Iron Curtain’ between East and West
  • Examination of depressive signs and symptoms among 803 University students in seven Universities and Colleges. Hungary, Romania, Serbia.
  • Examination of spirituality and the dimensions of spirituality among 803 students in seven different Universities. Hungary, Romania and Serbia.
  • Examination of depressive signs and symptoms among 932 students in eight different secondary schools in Hungary

Research News

  • Brain-derived neurotrophic factor levels in combat veterans with or without a history of suicide attempt
  • Pro-inflammatory cytokines and suicidality in patients with bipolar disorder
  • Thirty years of publications in the field of suicidology
  • Osteoporosis drugs are associated with depression and anxiety

Latest News

  • Leading world experts on suicide. Expertscape, the June 20, 2022, report
  • The U.S. Department of Veterans Affairs offers large prizes for suicide prevention ideas
  • Suicide mortality in the U.S. decreased from 2018 to 2020 after increasing since 2000
  • The World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Men’s Mental Health – January 2022 update

Interviews with eminent psychiatrists

  • Interview with Professor Shih-Ku Lin
  • Interview with Professor Masahito Fushimi
  • Interview with Professor Maurizio Pompili
  • Interview with Professor Marco Sarchiapone

Ten Years Ago

  • Teaching medical professionals and trainees about suicide prevention
  • Suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors
  • Treatment of suicide attempters with bipolar disorder: a randomized clinical trial
  • Posttraumatic stress disorder and the Neuroevolutionary Time-depth Principle

Back to Top

  • About
  • Contact
  • Privacy Policy
  • Terms and Conditions
Copyright © 2022 AVCalc LLC. All rights reserved worldwide.